Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03265249 · ClinicalTrials.gov registry record · NA
BRIDGE Device for Post-operative Pain Control
A NA study, sponsored by Duke University.
- Terminated
- Registry status
- NA
- Development phase
- 27
- Enrollment target
NCT03265249 is a NA study that was terminated before completion, run by Duke University. The registered enrollment target is 27 participants.
The verdict
NCT03265249, a NA study, was terminated before completion, sponsored by Duke University.
- TERMINATED
- Registry status
- NA
- Development phase
- 27 participants
- Enrollment target
Study Summary
Auricular neurostimulation is a potential novel and non-invasive method of pain control following liver transplantation in a growing patient population with the probability of significant impact on economics and morbidity. The investigators propose a pilot study to investigate the effects of auricular neurostimulation in patients receiving a liver transplantation. The investigator will investigate the effects of auricular neurostimulation with this novel device and compare it to the current standard of care for pain management following liver transplantation.
Interventions
- DEVICE BRIDGE device
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 27 participants |
| Start Date | 2018-02-12 |
| Est. Completion | 2020-04-03 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03265249
The ClinicalTrials.gov registry entry for NCT03265249 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 27 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Duke University, which has 1,725 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which BRIDGE device is the first listed.
NCT03265249 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03265249 about?
NCT03265249 is a clinical study titled "BRIDGE Device for Post-operative Pain Control". Auricular neurostimulation is a potential novel and non-invasive method of pain control following liver transplantation in a growing patient population with the probability of significant impact on economics and morbidity. The investigators propose a pilot study to investigate the effects of auricul...
What is the current status of trial NCT03265249?
This trial is currently terminated. It is a NA study. The enrollment target is 27 participants. The study started on 2018-02-12. Estimated completion is 2020-04-03.
What interventions are being tested in trial NCT03265249?
The interventions under investigation include: BRIDGE device (DEVICE).
Who is sponsoring clinical trial NCT03265249?
This trial is sponsored by Duke University, which has 1,725 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.